Coprococcus comes
Coprococcus Comes: An Emerging Player in Gut Health
Description:
Coprococcus comes is a Gram-negative, anaerobic bacterium found in the human gut microbiome. It belongs to the Ruminococcaceae family, a prominent group of bacteria associated with fiber fermentation and butyrate production. Coprococcus comes is a dominant bacterial species in the fecal microbiota of healthy individuals, comprising up to 10% of the total population.
Associated Diseases:
Recent research has linked alterations in Coprococcus comes levels to various health conditions:
- Inflammatory Bowel Disease (IBD): Studies suggest that decreased levels of Coprococcus comes are associated with the development and severity of IBD, including ulcerative colitis and Crohn‘s disease.
- Colorectal Cancer: A correlation has been found between low abundance of Coprococcus comes and an increased risk of colorectal cancer. This bacterium produces butyrate, a short-chain fatty acid with anti-inflammatory and anti-tumor properties.
- Metabolic Syndrome: Individuals with metabolic syndrome, characterized by obesity, hypertension, and insulin resistance, exhibit lower levels of Coprococcus comes in their gut microbiota.
- Non-Alcoholic Fatty Liver Disease (NAFLD): Reduced abundance of Coprococcus comes is associated with the development and progression of NAFLD, suggesting its potential role in liver health.
Did you Know ?
According to a meta-analysis of 15 studies, individuals with IBD had a 36% lower relative abundance of Coprococcus comes compared to healthy controls. This significant difference highlights the importance of this bacterium in maintaining intestinal homeostasis.
